Yang Wang

6.5k total citations · 3 hit papers
178 papers, 4.6k citations indexed

About

Yang Wang is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Yang Wang has authored 178 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Molecular Biology, 33 papers in Infectious Diseases and 26 papers in Epidemiology. Recurrent topics in Yang Wang's work include Pharmacological Effects of Natural Compounds (8 papers), Inflammasome and immune disorders (7 papers) and Tuberculosis Research and Epidemiology (7 papers). Yang Wang is often cited by papers focused on Pharmacological Effects of Natural Compounds (8 papers), Inflammasome and immune disorders (7 papers) and Tuberculosis Research and Epidemiology (7 papers). Yang Wang collaborates with scholars based in China, United States and Japan. Yang Wang's co-authors include Peng Zhang, Lixin Lou, Kaiyu Zhang, Rongli Piao, Chen Yu, Juliane Bubeck Wardenburg, Naoko Inoshima, Ichiro Inoshima, Michael E. Powers and Georgia Wilke and has published in prestigious journals such as Nature, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Yang Wang

167 papers receiving 4.5k citations

Hit Papers

Allelic reprogramming of 3D chromatin architecture during... 2017 2026 2020 2023 2017 2019 2022 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yang Wang China 35 2.0k 772 633 509 429 178 4.6k
José Manuel Pérez de la Lastra Spain 38 1.8k 0.9× 984 1.3× 663 1.0× 433 0.9× 279 0.7× 130 6.5k
Allyson L. Byrd United States 19 2.0k 1.0× 656 0.8× 1.1k 1.8× 871 1.7× 443 1.0× 22 5.9k
Yue Shen China 30 2.0k 1.0× 463 0.6× 460 0.7× 474 0.9× 246 0.6× 110 4.1k
Julia Oh United States 35 2.2k 1.1× 695 0.9× 485 0.8× 1.1k 2.1× 426 1.0× 93 7.0k
Amanda E. Ramer‐Tait United States 38 2.7k 1.3× 567 0.7× 905 1.4× 655 1.3× 731 1.7× 105 4.8k
Xiaokui Guo China 40 2.2k 1.1× 1.0k 1.3× 343 0.5× 625 1.2× 209 0.5× 209 5.3k
Clayton Deming United States 14 1.8k 0.9× 666 0.9× 850 1.3× 864 1.7× 325 0.8× 20 5.1k
Yin Wang China 34 1.2k 0.6× 441 0.6× 362 0.6× 620 1.2× 217 0.5× 244 4.3k
Dipshikha Chakravortty India 43 2.0k 1.0× 621 0.8× 1.1k 1.8× 460 0.9× 318 0.7× 193 5.8k
David F. Lappin United Kingdom 45 1.1k 0.5× 918 1.2× 1.0k 1.6× 474 0.9× 579 1.3× 147 4.9k

Countries citing papers authored by Yang Wang

Since Specialization
Citations

This map shows the geographic impact of Yang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Wang more than expected).

Fields of papers citing papers by Yang Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Wang. The network helps show where Yang Wang may publish in the future.

Co-authorship network of co-authors of Yang Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yang Wang. A scholar is included among the top collaborators of Yang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yang Wang. Yang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Sheng, et al.. (2025). Dysregulated tryptophan metabolism and gut microbiota in chronic hypoxia-induced pulmonary hypertension rats. Journal of Pharmaceutical and Biomedical Analysis. 266. 117111–117111.
3.
Lv, Mengying, Yang Wang, Zhengtao Wang, et al.. (2024). Combined gut microbiome and metabolomics to reveal the mechanism of proanthocyanidins from the roots of Ephedra sinica Stapf on the treatment of ulcerative colitis. Journal of Pharmaceutical and Biomedical Analysis. 249. 116351–116351.
4.
Wang, Yang, Kai Zhang, Wen‐Mei Chen, et al.. (2024). Gut Microbiome-Serum Metabolism Revealed the Allergenicity of Ferulic Acid Combined with Glucose-Modified β-Lactoglobulin. Journal of Agricultural and Food Chemistry. 72(20). 11746–11758. 1 indexed citations
5.
Wang, Wenjun, Yu Liu, Dong Chen, et al.. (2024). “Convex Lens” of DNA damage: A nanomedicine enhances anti-PD-1 immunotherapy as immunogenic cell death inducer for “cold” melanoma. Nano Today. 61. 102598–102598. 1 indexed citations
6.
Wang, Yao, Yan Wang, Jianjie Huang, et al.. (2023). TR score: A noninvasive model to predict histological stages in patients with primary biliary cholangitis. Frontiers in Immunology. 14. 1152294–1152294. 2 indexed citations
7.
Bai, Chenjun, Ji‐Man Hong, Qing Hao Miow, et al.. (2023). CENTRAL NERVOUS SYSTEM TUBERCULOSIS IMMUNOPATHOLOGY IS DRIVEN BY MATRIX DESTRUCTION WITH MATRIX METALLOPROTEINASES INHIBITION REDUCING INFLAMMATION AND IMPROVING SURVIVAL. International Journal of Infectious Diseases. 130. S6–S7. 1 indexed citations
8.
Yang, Feng, Xiaofan Li, Yang Wang, et al.. (2021). A study on willingness and influencing factors to receive COVID-19 vaccination among Qingdao residents. Human Vaccines & Immunotherapeutics. 17(2). 408–413. 13 indexed citations
9.
Ye, Yinyin, Adam Swensen, Yang Wang, et al.. (2021). A Pilot Study of Urine Proteomics in COVID-19–Associated Acute Kidney Injury. Kidney International Reports. 6(12). 3064–3069. 4 indexed citations
10.
Takashima, Hiroki, Yoshikatsu Koga, Shino Manabe, et al.. (2021). Radioimmunotherapy with an 211At‐labeled anti–tissue factor antibody protected by sodium ascorbate. Cancer Science. 112(5). 1975–1986. 12 indexed citations
11.
Luan, Wenjing, Xiaolei Liu, Xuefei Wang, et al.. (2019). Inhibition of Drug Resistance of Staphylococcus aureus by Efflux Pump Inhibitor and Autolysis Inducer to Strengthen the Antibacterial Activity of β-lactam Drugs. Polish Journal of Microbiology. 68(4). 477–491. 6 indexed citations
12.
13.
Giuntini, Serena, Matteo Stoppato, Maja Sedic, et al.. (2018). Identification and Characterization of Human Monoclonal Antibodies for Immunoprophylaxis against Enterotoxigenic Escherichia coli Infection. Infection and Immunity. 86(8). 19 indexed citations
14.
Wang, Dongshu, et al.. (2018). Expression of MicroRNA-448 and SIRT1 and Prognosis of Obese Type 2 Diabetic Mellitus Patients After Laparoscopic Bariatric Surgery. Cellular Physiology and Biochemistry. 45(3). 935–950. 17 indexed citations
15.
Wang, Yang, Ji Chen, Keda Zhang, et al.. (2018). Chemical Composition, Proapoptotic and Antiosteoporosis Activities of the Essential Oil from the Aerial Part of <i>Alpinia officinarum</i> Hance. Chinese Medicine. 9(3). 144–164. 1 indexed citations
16.
Wang, Yang, et al.. (2018). Research advances on clinical applications of cell-free DNA from peripheral blood in liver cancer. Zhonghua gan-dan waike zazhi. 24(5). 348–351.
18.
Wang, Yang, et al.. (2015). Establishment of Plantlet Regeneration System of Autotetraploid Paulownia kawakamii in Vitro. He'nan nongye kexue. 44(7). 119–123. 1 indexed citations
19.
Yang, Jun-Song, Lei Chu, Dongjie Zhang, et al.. (2014). Anterior retropharyngeal approach to C1 for percutaneous vertebroplasty under C-arm fluoroscopy. The Spine Journal. 15(3). 539–545. 11 indexed citations
20.
Shi, Lili, Sun Zongxiu, Yang Wang, et al.. (2004). Agrobacterium-rnediated Transformation of Rice (Oryza sativa L) with atzA Gene. Zhongguo nongye Kexue. 37(8). 1093–1098. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026